In LS patients with colorectal cancer, it was possible to identify that TP53 variants modulated the age of development of CRC, with the age of tumor development being earlier in patients with TP53 mutations than in LS patients who presented wild-type (WT) TP53 [43]. Here, TP53 is linked to colorectal carcinoma.